Reagents
Ended Awarded Last action
- Contract number
- 36C25022N0231
- Awardee
-
Immucor Inc. UEI KV8AGJX7NMZ7
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $27,987
Award facts
- Contract value 37% obligated
-
- $40,135.07 Current, with exercised options
- $76,580.39 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $2,931 | |
| Supplemental Agreement for work within scope | $12,907 | |
| Other Administrative Action | $0 | |
| Original award | $12,148 |
About this award
This is a contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic reagents, test kits, and related equipment. The award, valued at $76,580.39, is a Blanket Purchase Agreement (BPA) call order under Immucor's General Services Administration (GSA) Federal Supply Schedule contract for "In Vitro Diagnostics, Reagents, Test" products.
The contract was awarded by the U.S. Department of Veterans Affairs (VA) for the provision of unspecified "REAGENTS" in support of the VA's healthcare operations. The contract has an ultimate completion date of July 11, 2022 and utilizes a Firm Fixed Price pricing structure. There is no set-aside designation associated with this award.
Immucor has a history of providing specialized blood banking and immunohematology products and services to various federal agencies, including the VA, the Defense Health Agency, and the Indian Health Service. This BPA call order represents an ongoing procurement of critical medical supplies through a pre-established IDIQ contract vehicle, facilitating reliable access to Immucor's proprietary reagents and instruments.
Quick answers
Who was awarded contract 36C25022N0231?
36C25022N0231 was awarded to Immucor Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 1, 2022.
How much is contract 36C25022N0231 worth?
The government has obligated $27,987 on 36C25022N0231. Its current value, with exercised options, is $40,135. Its potential value, with all options, is $76,580.
Is contract 36C25022N0231 an order under another contract?
Yes. 36C25022N0231 is a BPA call under V797D70110-36C25018A0011, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25022N0231 competed?
The extent of competition for 36C25022N0231 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award